It does not cause photosensitivity (unlike retinoids), does not thin the skin (unlike corticosteroids), and does not require a tolerance-building period
[DOI] [PubMed] [Google Scholar] 22.Roberto-Rodrigues M, Fernandes RM, Senos R, Scoralick AC, Bastos AL, Santos TM, et al
Interestingly, the opioid antagonist naloxone can block some of DSIPs effects, confirming this opioid system involvement
For researchers focused on fat loss applications , understanding this dual mechanism explains why cagrilintide alone produces meaningful but moderate weight loss (around 11.8% in phase 3 data), while the combination pushes results dramatically higher
Rest in the clinic for a moment
Passed: Confirms active ingredient concentration is within 10% of the label claim